|
2023
|
Invention
|
Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for dr... |
|
2022
|
Invention
|
Therapeutic agents comprising oncolytic vaccinia viruses and nk cells, and uses thereof for drugs... |
|
2021
|
Invention
|
Isolated oncolytic adenovirus capable of expressing exogenous gene, vector, therapeutic agent, an... |
|
|
Invention
|
Isolated recombinant oncolytic poxvirus capable of being regulated and controlled by microrna and... |
|
2020
|
Invention
|
Method for producing virus and harvest liquid composition.
The present invention provides a meth... |
|
|
Invention
|
Method for producing virus and harvest liquid composition. Provided are a method for producing a ... |
|
|
Invention
|
Therapeutic agent containing isolated recombinant oncolytic adenovirus and immune cells and use t... |
|
2019
|
Invention
|
Therapeutic agents comprising nucleic acids and car-modified immune cells, and uses thereof. Prov... |
|
|
Invention
|
Therapeutic agents comprising nucleic acids and tcr modified immune cells and uses thereof. A the... |
|
|
Invention
|
Therapeutic agent comprising nucleic acid and car-modified immune cell and application thereof. P... |
|
|
Invention
|
Isolated t-cell receptor, modified cell, encoding nucleic acid and use thereof. Provided are an i... |
|
|
Invention
|
Therapeutic agent comprising nucleic acid and tcr modified immune cell and use thereof. A therape... |
|
2018
|
Invention
|
Isolated t-cell receptor, cell modified by same, coding nucleic acids, expression vector, prepara... |
|
|
Invention
|
Therapeutic agent comprising isolated recombinant oncolytic adenovirus and nk cell, application, ... |
|
|
Invention
|
Isolated recombinant oncolytic adenovirus, pharmaceutical composition, and application of isolate... |
|
|
Invention
|
Therapeutic agent comprising oncolytic virus and car-nk cells, use, kit and method for treating t... |
|
|
Invention
|
Isolated recombinant oncolytic poxvirus, pharmaceutical composition, and use thereof in treatment... |
|
|
Invention
|
Therapeutic agent containing isolated recombinant oncolytic poxvirus and nk cells, application th... |
|
|
Invention
|
Application of oncolytic viruses as immunostimulants for treatment of tumors and/or cancers. Prov... |
|
|
Invention
|
Application of oncolytic virus as immunostimulant for treating tumors and/or cancers. Application... |
|
|
Invention
|
Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancers. The present... |
|
|
Invention
|
Therapeutic agent and application thereof in drugs for treating tumors and/or cancer. The present... |
|
|
Invention
|
Therapeutic agent comprising oncolytic viruses and nk cells and application thereof in drugs for ... |
|
2017
|
Invention
|
Method for establishing machine learning model for predicting toxicity of sirna to certain type o... |
|
|
Invention
|
Method for establishing machine learning model for predicting toxicity of sirna against certain t... |
|
2016
|
Invention
|
Oral preparation and preparation method thereof. An oral preparation for treating cell proliferat... |
|
|
Invention
|
Drug inclusion compound, preparation thereof, and preparation method therefor. A pharmaceutical c... |
|
|
Invention
|
Oral preparation and preparation method therefor. An oral preparation for treating cell prolifera... |
|
|
Invention
|
In vivo individualized systemic immunotherapeutic method and device. The invention provides an in... |
|
2014
|
Invention
|
In-vivo individualized system immunological therapeutic method and device. An in-vivo individuali... |
